These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

228 related articles for article (PubMed ID: 31461490)

  • 1. Oncostatin M reduces atherosclerosis development in APOE*3Leiden.CETP mice and is associated with increased survival probability in humans.
    Keulen DV; Pouwer MG; Emilsson V; Matic LP; Pieterman EJ; Hedin U; Gudnason V; Jennings LL; Holmstrøm K; Nielsen BS; Pasterkamp G; Lindeman JHN; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
    PLoS One; 2019; 14(8):e0221477. PubMed ID: 31461490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inflammatory cytokine oncostatin M induces endothelial activation in macro- and microvascular endothelial cells and in APOE*3Leiden.CETP mice.
    van Keulen D; Pouwer MG; Pasterkamp G; van Gool AJ; Sollewijn Gelpke MD; Princen HMG; Tempel D
    PLoS One; 2018; 13(10):e0204911. PubMed ID: 30273401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The AB loop of oncostatin M (OSM) determines species-specific signaling in humans and mice.
    Adrian-Segarra JM; Sreenivasan K; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 Dec; 293(52):20181-20199. PubMed ID: 30373773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The AB loop and D-helix in binding site III of human Oncostatin M (OSM) are required for OSM receptor activation.
    Adrian-Segarra JM; Schindler N; Gajawada P; Lörchner H; Braun T; Pöling J
    J Biol Chem; 2018 May; 293(18):7017-7029. PubMed ID: 29511087
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Murine Oncostatin M Acts via Leukemia Inhibitory Factor Receptor to Phosphorylate Signal Transducer and Activator of Transcription 3 (STAT3) but Not STAT1, an Effect That Protects Bone Mass.
    Walker EC; Johnson RW; Hu Y; Brennan HJ; Poulton IJ; Zhang JG; Jenkins BJ; Smyth GK; Nicola NA; Sims NA
    J Biol Chem; 2016 Oct; 291(41):21703-21716. PubMed ID: 27539849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncostatin M receptor β deficiency attenuates atherogenesis by inhibiting JAK2/STAT3 signaling in macrophages.
    Zhang X; Li J; Qin JJ; Cheng WL; Zhu X; Gong FH; She Z; Huang Z; Xia H; Li H
    J Lipid Res; 2017 May; 58(5):895-906. PubMed ID: 28258089
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oncostatin M pathway plays a major role in the renal acute phase response.
    Luyckx VA; Cairo LV; Compston CA; Phan WL; Mueller TF
    Am J Physiol Renal Physiol; 2009 Apr; 296(4):F875-83. PubMed ID: 19158344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A unique loop structure in oncostatin M determines binding affinity toward oncostatin M receptor and leukemia inhibitory factor receptor.
    Chollangi S; Mather T; Rodgers KK; Ash JD
    J Biol Chem; 2012 Sep; 287(39):32848-59. PubMed ID: 22829597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of a splice variant of oncostatin M receptor beta in human esophageal squamous carcinoma.
    Kausar T; Sharma R; Hasan MR; Saraya A; Chattopadhyay TK; Gupta SD; Ralhan R
    Cell Oncol (Dordr); 2011 Jun; 34(3):177-87. PubMed ID: 21394648
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas.
    Chen D; Chu CY; Chen CY; Yang HC; Chiang YY; Lin TY; Chiang IP; Chuang DY; Yu CC; Chow KC
    J Pathol; 2008 Jul; 215(3):290-9. PubMed ID: 18491353
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of oncostatin M on human cerebral endothelial cells and expression in inflammatory brain lesions.
    Ruprecht K; Kuhlmann T; Seif F; Hummel V; Kruse N; Brück W; Rieckmann P
    J Neuropathol Exp Neurol; 2001 Nov; 60(11):1087-98. PubMed ID: 11706938
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oncostatin M drives intestinal inflammation and predicts response to tumor necrosis factor-neutralizing therapy in patients with inflammatory bowel disease.
    West NR; Hegazy AN; Owens BMJ; Bullers SJ; Linggi B; Buonocore S; Coccia M; Görtz D; This S; Stockenhuber K; Pott J; Friedrich M; Ryzhakov G; Baribaud F; Brodmerkel C; Cieluch C; Rahman N; Müller-Newen G; Owens RJ; Kühl AA; Maloy KJ; Plevy SE; ; Keshav S; Travis SPL; Powrie F
    Nat Med; 2017 May; 23(5):579-589. PubMed ID: 28368383
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of Oncostatin M Signaling in Adipocytes Induces Insulin Resistance and Adipose Tissue Inflammation in Vivo.
    Elks CM; Zhao P; Grant RW; Hang H; Bailey JL; Burk DH; McNulty MA; Mynatt RL; Stephens JM
    J Biol Chem; 2016 Aug; 291(33):17066-76. PubMed ID: 27325693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-oncostatin M antibody inhibits the pro-malignant effects of oncostatin M receptor overexpression in squamous cell carcinoma.
    Kucia-Tran JA; Tulkki V; Scarpini CG; Smith S; Wallberg M; Paez-Ribes M; Araujo AM; Botthoff J; Feeney M; Hughes K; Caffarel MM; Coleman N
    J Pathol; 2018 Mar; 244(3):283-295. PubMed ID: 29205362
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncostatin M is expressed in atherosclerotic lesions: a role for Oncostatin M in the pathogenesis of atherosclerosis.
    Albasanz-Puig A; Murray J; Preusch M; Coan D; Namekata M; Patel Y; Dong ZM; Rosenfeld ME; Wijelath ES
    Atherosclerosis; 2011 Jun; 216(2):292-8. PubMed ID: 21376322
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oncostatin M (OSM) cytostasis of breast tumor cells: characterization of an OSM receptor beta-specific kernel.
    Underhill-Day N; Heath JK
    Cancer Res; 2006 Nov; 66(22):10891-901. PubMed ID: 17108126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncostatin M, A Profibrogenic Mediator Overexpressed in Non-Alcoholic Fatty Liver Disease, Stimulates Migration of Hepatic Myofibroblasts.
    Foglia B; Sutti S; Pedicini D; Cannito S; Bocca C; Maggiora M; Bevacqua MR; Rosso C; Bugianesi E; Albano E; Novo E; Parola M
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mice overexpressing murine oncostatin M (OSM) exhibit changes in hematopoietic and other organs that are distinct from those of mice overexpressing human OSM or bovine OSM.
    Juan TS; Bolon B; Lindberg RA; Sun Y; Van G; Fletcher FA
    Vet Pathol; 2009 Jan; 46(1):124-37. PubMed ID: 19112126
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The AT04A vaccine against proprotein convertase subtilisin/kexin type 9 reduces total cholesterol, vascular inflammation, and atherosclerosis in APOE*3Leiden.CETP mice.
    Landlinger C; Pouwer MG; Juno C; van der Hoorn JWA; Pieterman EJ; Jukema JW; Staffler G; Princen HMG; Galabova G
    Eur Heart J; 2017 Aug; 38(32):2499-2507. PubMed ID: 28637178
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The inflammatory mediator oncostatin M induces angiopoietin 2 expression in endothelial cells in vitro and in vivo.
    Rychli K; Kaun C; Hohensinner PJ; Rega G; Pfaffenberger S; Vyskocil E; Breuss JM; Furnkranz A; Uhrin P; Zaujec J; Niessner A; Maurer G; Huber K; Wojta J
    J Thromb Haemost; 2010 Mar; 8(3):596-604. PubMed ID: 20088942
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.